Dimericon Therapeutics
- Biotech or pharma, therapeutic R&D
Dimericon Therapeutics is a seed-stage biotech company developing pre-clinical programs for hard-to-drug targets using a novel cross-linked helix dimer platform.
June 16-19, 2025
Boston Convention & Exhibition Center
Dimericon Therapeutics is a seed-stage biotech company developing pre-clinical programs for hard-to-drug targets using a novel cross-linked helix dimer platform.